Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-2638-2026

Baxter Healthcare Corporation recalls Adapter for Head Positioning

Baxter Healthcare CorporationDeerfield, IL, United StatesReported Jul 8, 2026 · 10 days ago
Legal News Analyst ·

Reason for recall

The Adapter for Head Positioning accessory may become loose during patient positioning and unintentionally move when used in conjunction with the side rails of the Upper Back Section H V U component on Baxter operating tables.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Adapter for Head Positioning, Model/Catalog Number: 1739994, when used in conjunction with the side rails of the Upper Back Section H V U component (product code 1909813) on Baxter operating tables
    UDI-DI 00887761972780
    15 affected lots
    173999400887761972780109931797109931798109931799109943588109943590109948550
    +7 more109964963109964964109964969109964970109964971109980700110006694

What the firm is doing

An URGENT PRODUCT RECALL notification letter dated 4/20/26 was sent to customers. Actions to be Taken by Customers 1. Please notify all users of the product affected within your facility, especially all operating room staff. The affected Adapters may continue to be used only when mounted directly to the side rails of the operating table back plate. Do not use the Adapter on the Upper Back Section H V U side rails (component). Using the Upper Back Section H V U (separate component which is attached to the operating table s back plate) in conjunction with the Adapter accessory must be stopped/ceased, until a replacement takes place. 2. Once the newly designed Adapters are available Baxter will contact customers with instructions for return and replacement of the impacted Adapters. 3. If you received this communication directly from Baxter, acknowledge receipt by following the within the body of the corresponding email. Acknowledging receipt of this notification will prevent you from receiving repeated notices. If you do not complete the acknowledgement, you will receive a phone call from Accenture LLP on behalf of Baxter to confirm your receipt of this notification. 4. If you purchased this product from a distributor or wholesaler, please contact your supplier to arrange for return of the affected product. Please note that responding on the Baxter customer portal is not applicable. If a response is requested by your distributor or wholesaler, please respond to them according to their instructions. 5. Please forward a copy of this communication to the director of nursing, facility risk manager, patient safety, biomedical engineering department, director of surgical services, operating room staff, and any other departments within your institution who use the affected product. 6. If you are a dealer, wholesaler, distributor/reseller, or original equipment manufacturer (OEM) that distributed any affected product to other facilities, please conduct a user-level recall of

DistributionShow details

Worldwide - US Nationwide distribution in the states of Minnesota, Maryland, and Pennsylvania and the countries of Canada, Hong Kong, India, Japan, Korea, Philippines, Taiwan, Thailand, Vietnam, Austria, Belgium, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iraq, Israel, Italy, Jordan, Kenya, Lebanon, Libya, Malta, Morocco, Netherlands, Norway, Oman, Pakistan, Poland, Portugal, Qatar, Romania, Saudi Arabia, Senegal, Serbia, Slovakia, Spain, Sweden, Switzerland, Tunisia, Turkey, United Arabia Emrites, Ukraine, Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls